BIFIDO Co., Ltd produces probiotics based products. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $2.09 | N/A |
Market Cap | $8.56M | N/A |
Shares Outstanding | 4.09M | N/A |
Employees | 0 | N/A |